Demographic Data and Pathology
Subject | Age (y) | Sex | WHO performance status | Pathology | Smoking status | Prior antineoplastic chemotherapy (CT) or tyrosine kinase inhibitor (TKI) therapy |
---|---|---|---|---|---|---|
0701-0002 | 63 | Male | 0 | Large cell carcinoma | Ever | 1 CT regimen |
0701-0003 | 47 | Male | 1 | Adenocarcinoma | Current | 2 CT regimens |
0701-0004 | 58 | Male | 1 | Squamous cell carcinoma | Ever | 1 CT regimen |
0701-0005 | 65 | Male | 1 | Adenocarcinoma | Ever | 2 CT regimens + 1 EGFR-TKI regimen |
0601-0001 | 57 | Female | 1 | Adenocarcinoma | Ever | 1 CT regimen |
0601-0003 | 56 | Female | 2 | Squamous cell carcinoma | Ever | 2 CT regimens |
0601-0007 | 52 | Female | 0 | Adenocarcinoma | Current | 1 CT regimen |
0601-0009 | 74 | Male | 2 | Adenocarcinoma | Ever | 1 CT regimen |
Smoking status: ever smokers were subjects who had smoked at least 100 cigarettes or cigars in their lifetime.